I look at two ASX-listed ‘microcap’ companies born in Canberra and are taking their expertise to the world.
It is a very esoteric niche on the ASX, but regenerative medicine is a fascinating area. ASX-listed companies PolyNovo, AVITA Medical and AROA Biosurgery all focus on regenerative medicine and soft-tissue repair, targeting severe burns, trauma and complex wounds, using active biological or structural reconstruction.
I went looking for ASX companies that are genuine disruptors trading at attractive prices. I found two global software stars taking on decades-old legacy systems […]
Two beaten-down stocks are showing signs of life, and in both cases, a hard-fought push into the US market is the reason why.
Drones have gone from novelty gadgets to front-line weapons in barely a decade, and the money is following fast. Here's where the ASX fits into that story.
Here are two ASX-listed fund manager "incubators" that look compelling right now.
Here are two situations that have recently been described as "transformational" where I would be prepared to bet on a positive outcome.
As the burgeoning demand for AI infrastructure, electrification, the 'energy transition' and defence systems intersects with years of under-investment in mining, many commodities are surging in price and top of the tree is copper. Here are two producers that stand out in terms of value they offer at current share prices.
Here are two small-cap stocks that look to be very good buying at current prices.
I maintain that 'founder-led' companies make up a fascinating little cohort of the ASX and here are two great examples, in very different businesses, that appear to be good buying at current prices.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.